A cost-benefit analysis of intensive therapy.
The daily costs of 90 critically ill patients treated on an intensive therapy unit were calculated on an individual patient basis.
Twenty-one patients (23%) died on the intensive therapy unit and another 13 (15%) died within one year of discharge.
The results demonstrate that there is wide variation in costs among the patients and the diagnoses.
The mean daily cost of nonsurvivors was almost £300 greater than that of survivors (£816 (95% confidence interval =£649-982) versus £550 (£498-601)). Renal failure, sepsis and pneumonia proved to be some of the most expensive conditions to treat, and postoperative respiratory failure the cheapest.
Mots-clés Pascal : Analyse avantage coût, Survie, Insuffisance rénale, Complication, Mortalité, Unité soin intensif, Hôpital, Economie santé, Homme, Réanimation, Grande Bretagne, Royaume Uni, Europe
Mots-clés Pascal anglais : Cost benefit analysis, Survival, Renal failure, Complication, Mortality, Intensive care unit, Hospital, Health economy, Human, Resuscitation, Great britain, United Kingdom, Europe
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0298790
Code Inist : 002B27B14C. Création : 199406.